γ-Aminobutyric acid-rich yogurt fermented by Streptococcus salivarius subsp. thermophiles fmb5 apprars to have anti-diabetic effect on streptozotocin-induced diabetic mice

Journal of Functional Foods

Volumn 20, Issue , 2016, Pages 267-275

  Chen, Lin ^a   Zhao, Haizhen ^a   Zhang, Chong ^a   Lu, Yingjian ^b   Zhu, Xiaoyu ^a   Lu, Zhaoxin ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Blood glucose; Diabetes; Insulin; Streptozotocin induced diabetic mice; Aminobutyric acid rich yogurt

Indexed keywords

EID: 84953380661     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.10.030     Document Type: Article

References (40)

1. Abdou A.M., Higashiguchi S., Horie K., Kim M., Hatta H., Yokogoshi H. Relaxation and immunity enhancement effects of γ-aminobutyric acid (GABA) administration in humans. Biofactors (Oxford, England) 2006, 26:201-208.
2. American Diabetes Association Peripheral arterial disease in people with diabetes. Journal of the American Podiatric Medical Association 2005, 95:309-319.
3. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69.
4. Aoki H., Furuya Y., Endo Y., Fujimoto K. Effect of γ-aminobutyric acid-enriched tempeh-like fermented soybean (GABA-tempeh) on the blood pressure of spontaneously hypertensive rats. Bioscience, Biotechnology, and Biochemistry 2003, 67:1806-1808.
5. Bansal P., Wang Q. Insulin as a physiological modulator of glucagon secretion. American Journal of Physiology. Endocrinology and Metabolism 2008, 295:E751-E761.
6. Bluestone J.A., Herold K., Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010, 464:1293-1300.
7. Botek G., Anderson M.A., Taylor R. Charcot neuroarthropathy: An often overlooked complication of diabetes. Cleveland Clinic Journal of Medicine 2010, 77:593-599.
8. Braun M., Ramracheya R., Bengtsson M., Clark A., Walker J.N., Johnson P.R., Rorsman P. γ-Aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic β-cells. Diabetes 2010, 59:1694-1701.
9. Cossart R., Bernard C., Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: Multiple fates of GABA signalling in epilepsies. Trends in Neurosciences 2005, 28:108-115.
10. Franklin V., Khan F., Kennedy G., Belch J., Greene S. Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes. Diabetologia 2008, 51:353-360.
11. Goh S.-Y., Cooper M.E. The role of advanced glycation end products in progression and complications of diabetes. The Journal of Clinical Endocrinology and Metabolism 2008, 93:1143-1152.
12. Hayakawa K., Kimura M., Kasaha K., Matsumoto K., Sansawa H., Yamori Y. Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. British Journal of Nutrition 2004, 92:411-417.
13. Houser C.R. GABA neurons in seizure disorders: A review of immunocytochemical studies. Neurochemical Research 1991, 16:295-308.
14. Inoue K., Shirai T., Ochiai H., Kasao M., Hayakawa K., Kimura M., Sansawa H. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. European Journal of Clinical Nutrition 2003, 57:490-495.
15. Jones S., Close C., Mattock M., Jarrett R., Keen H., Viberti G. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. British Medical Journal 1989, 298:487-490.
16. Jude E., Eleftheriadou I., Tentolouris N. Peripheral arterial disease in diabetes - A review. Diabetic Medicine: A Journal of the British Diabetic Association 2010, 27:4-14.
17. Kang Y.M., Qian Z.J., Lee B.J., Kim Y.M. Protective effect of GABA-enriched fermented sea tangle against ethanol-induced cytotoxicity in HepG2 cells. Biotechnology and Bioprocess Engineering: BBE 2011, 16:966-970.
18. Karladee D., Suriyong S. γ-Aminobutyric acid (GABA) content in different varieties of brown rice during germination. ScienceAsia: Journal of the Science Society of Thailand 2012, 38:13-17.
19. Kilpatrick E.S., Rigby A.S., Atkin S.L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 2007, 30:707-712.
20. Lamster I.B., Lalla E., Borgnakke W.S., Taylor G.W. The relationship between oral health and diabetes mellitus. The Journal of the American Dental Association 2008, 139:19S-24S.
21. Ligon B., Yang J., Morin S., Ruberti M., Steer M. Regulation of pancreatic islet cell survival and replication by γ-aminobutyric acid. Diabetologia 2007, 50:764-773.
22. Maritim A., Sanders R., Watkins J.B. Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical and Molecular Toxicology 2003, 17:24-38.
23. Marks J.B., Raskin P. Cardiovascular risk in diabetes: A brief review. Journal of Diabetes and Its Complications 2000, 14:108-115.
24. Mayer R.R., Cherry J.H., Rhodes D. Effects of heat shock on amino acid metabolism of cowpea cells. Plant Physiology 1990, 94:796-810.
25. Nakagawa T., Yokozawa T., Kim H.J., Shibahara N. Protective effects of gamma-aminobutyric acid in rats with streptozotocin-induced diabetes. Journal of Nutritional Science and Vitaminology 2005, 51:278-282.
26. Nathan D.M. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care 2014, 37:9-16.
27. Nomura M., Kimoto H., Someya Y., Furukawa S., Suzuki I. Production of γ-aminobutyric acid by cheese starters during cheese ripening. Journal of Dairy Science 1998, 81:1486-1491.
28. Okada T., Sugishita T., Murakami T., Murai H., Saikusa T., Horino T., Takahashi T. Effect of the defatted rice germ enriched with GABA for sleeplessness, depression, autonomic disorder by oral administration. Nihon Shokuhin Kagaku Kōgakkaishi 2000, 47:596-603.
29. Omori M., Yano T., Okamoto J., Tsushida T., Murai T., Higuchi M. Effect of anaerobically treated tea (Gabaron tea) on blood pressure of spontaneously hypertensive rats. Nippon Nôgeikagaku Kaishi 1987, 61:1449-1451.
30. Pereira D.I., Gibson G.R. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology 2002, 37:259-281.
31. Sasaki S., Yokozawa T., Cho E.J., Oowada S., Kim M. Protective role of γ-aminobutyric acid against chronic renal failure in rats. The Journal of Pharmacy and Pharmacology 2006, 58:1515-1525.
32. Schneider I., Kressel G., Meyer A., Krings U., Berger R.G., Hahn A. Lipid lowering effects of oyster mushroom (Pleurotus ostreatus) in humans. Journal of Functional Foods 2011, 3:17-24.
33. Soltani N., Qiu H., Aleksic M., Glinka Y., Zhao F., Liu R., Ng T. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:11692-11697.
34. Tian J., Dang H., Kaufman D.L. Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice. PLoS ONE 2011, 6:e25337.
35. Tian J., Dang H.N., Yong J., Chui W.-S., Dizon M.P., Yaw C.K., Kaufman D.L. Oral treatment with γ-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE 2011, 6:e25338.
36. Tian J., Lu Y., Zhang H., Chau C.H., Dang H.N., Kaufman D.L. γ-Aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. The Journal of Immunology 2004, 173:5298-5304.
37. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
38. Tura A., Kautzky-Willer A., Pacini G. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT. Diabetes Research and Clinical Practice 2006, 72:298-301.
39. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
40. Xu E., Kumar M., Zhang Y., Ju W., Obata T., Zhang N., Ebina Y. Intra-islet insulin suppresses glucagon release via GABA-GABA A receptor system. Cell Metabolism 2006, 3:47-58.